NCT07316140

fullPIERS Model in the Prediction of Adverse Maternal Outcomes in Preeclampsia

A Prospective Study of Validation of the fullPIERS Model in the Prediction of Adverse Maternal Outcomes in Women With Pre- Eclampsia in Sohag University Hospital

• Status: Not Yet Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 50 (estimated)
• Sponsor: Sohag University · Academic / Other
• Sex: Female
• Age: —
• Healthy volunteers: Not accepted

Summary

Apredictive formula, fullPIERS (Pre-eclampsia Integrated Estimate of Risk Score), can be used to estimate the risk of suffering an adverse outcome using information obtained within 48 hours of admission with pre-eclampsia. The following information is used, serum creatinine, gestational age, platelet count,

Detailed description

Inclusion criteria Patients diagnosed with preeclampsia, defined by hypertension (systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg, measured twice more than 4 hours apart after 20 weeks gestation) Proteinuria of at least 0.3 g/dl or ≥300 mg of protein in a 24-hour urine collection Urine albumin-creatinine ratio (ACR) ≥30 mg/mmol, or hypertension with end organ dysfunction after20 weeks gestation

Conditions

• Preeclampsia
• Fullpairs

Timeline

• Start date: 2026-01-01
• Primary completion: 2026-01-01
• Completion: 2026-09-01
• First posted: 2026-01-05
• Last updated: 2026-01-05

Locations

1 site across 1 country: Egypt